SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-021357
Filing Date
2019-10-29
Accepted
2019-10-29 12:25:36
Documents
7
Period of Report
2019-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k1019_emmauslife.htm 8-K 18078
2 OPINION OF GIBSON, DUNN & CRUTCHER LLP f8k1019ex5-1_emmauslife.htm EX-5.1 6540
3 OCTOBER 29, 2019 PRESS RELEASE OF EMMAUS LIFE SCIENCES, INC. f8k1019ex99-1_emmauslife.htm EX-99.1 19085
4 GRAPHIC ex99-1_001.jpg GRAPHIC 12930
5 GRAPHIC image_001.jpg GRAPHIC 5269
6 GRAPHIC image_002.jpg GRAPHIC 2242
7 GRAPHIC image_007.jpg GRAPHIC 6997
  Complete submission text file 0001213900-19-021357.txt   83450
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 191175478
SIC: 8090 Services-Misc Health & Allied Services, NEC